ADVI Director Lindsay Bealor Greenleaf talks to Bloomberg Law
Greenleaf weighs in on the Trump Administration’s proposed rule on drug rebates and how the role they play will be both more transparent and defined.
[el-text]
***excerpt***
Greenleaf weighs in on the Trump Administration’s proposed rule on drug rebates and how the role they play will be both more transparent and defined.
***end excerpt***
***
[/el-text]
View full article here
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.